Literature DB >> 33073275

Structural insights into heparanase activity using a fluorogenic heparan sulfate disaccharide.

Liang Wu1, Norbert Wimmer2, Gideon J Davies1, Vito Ferro2.   

Abstract

A synthetic heparan sulfate disaccharide has been assessed as a fluorogenic heparanase substrate, enabling enzyme turnover and inhibition kinetics measurements despite slow turnover. Crystal structures with human heparanase also provide the first ever observation of a substrate in an activated 1S3 conformation, highlighting previously unknown interactions involved in enzymatic processing. Our data provide insights into the heparanase catalytic mechanism, and will inform the design of improved heparanase substrates and inhibitors.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33073275     DOI: 10.1039/d0cc05932c

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  3 in total

1.  Structural Insights into Pixatimod (PG545) Inhibition of Heparanase, a Key Enzyme in Cancer and Viral Infections.

Authors:  Mohit Chhabra; Jennifer C Wilson; Liang Wu; Gideon J Davies; Neha S Gandhi; Vito Ferro
Journal:  Chemistry       Date:  2022-01-31       Impact factor: 5.020

2.  Ultrasensitive small molecule fluorogenic probe for human heparanase.

Authors:  Jun Liu; Kelton A Schleyer; Tyrel L Bryan; Changjian Xie; Gustavo Seabra; Yongmei Xu; Arjun Kafle; Chao Cui; Ying Wang; Kunlun Yin; Benjamin Fetrow; Paul K P Henderson; Peter Z Fatland; Jian Liu; Chenglong Li; Hua Guo; Lina Cui
Journal:  Chem Sci       Date:  2020-10-20       Impact factor: 9.825

Review 3.  From Cancer to COVID-19: A Perspective on Targeting Heparan Sulfate-Protein Interactions.

Authors:  Mohit Chhabra; Gareth G Doherty; Nicholas W See; Neha S Gandhi; Vito Ferro
Journal:  Chem Rec       Date:  2021-06-19       Impact factor: 6.935

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.